Nanostructure for detecting viruses containing amphipathic polymer and diagnostic platform using the same

Patent metadata

Field	Value
Publication number	US-2024133888-A1
Application number	US-202318381221-A
Country	US
Kind code	A1
Filing date	Oct 17, 2023
Priority date	Oct 18, 2022
Publication date	Apr 25, 2024
Grant date	—

Abstract

The present disclosure relates to a nanostructure for detecting viruses including an amphipathic polymer, and a diagnostic platform using the same, wherein the nanostructure is capable of specifically detecting viruses through silica-based nanoparticles with excellent stability and high dispersion and a biocompatible amphipathic polymer, such that it is possible to develop a diagnostic platform with high sensitivity through binding and agglomeration of the nanostructure and viruses and enable rapid and accurate diagnosis of a target virus.

First claim

1 . A nanostructure for detecting viruses, comprising:
porous silica nanoparticles; an amphipathic polymer bound to a surface of the silica nanoparticles; and a virus antibody bound to the amphipathic polymer.

2 . The nanostructure of claim 1 , wherein the amphipathic polymer comprises any one or more selected from the group consisting of silane-poly(ethylene glycol)-COOH, polyethyleneimine (PEI), chitosan, polypropylene imine, polylysine, polyamidoamine, poly(allylamine), poly(diallyldimethylammonium chloride), poly(N-isopropyl acrylamide-co-acrylamide), poly(N-isopropylacrylamide-co-acrylic acid), diethylaminoethyl-dextran, poly(N-ethyl-vinylpyridinium bromide), poly(dimethylamino)ethyl methacrylate, poly(ethylene glycol)-co-poly(trimethylamino ethyl methacrylate chloride), and methoxy poly(ethylene glycol)-b-poly(D, L-lactide).

3 . The nanostructure of claim 1 , wherein the virus antibody comprises antibodies of any one or more selected from the group consisting of influenza A virus, influenza B virus, dengue virus, human respiratory syncytial virus, norovirus, MERS coronavirus, SARS coronavirus, and SARS coronavirus-2.

4 . The nanostructure of claim 3 , wherein the influenza A virus antibody comprises any one or more selected from the group consisting of H1N1 virus antibody, H2N2 virus antibody, H3N2 virus antibody, H5N1 virus antibody, H7N9 virus antibody, H7N7 virus antibody, H1N2 virus antibody, H9N2 virus antibody, H7N2 virus antibody, H7N3 virus antibody, H5N2 virus antibody, and H10N7 virus antibody.

5 . The nanostructure of claim 1 , wherein a carboxyl group of the amphipathic polymer and the antibody are bound and linked.

6 . The nanostructure of claim 1 , wherein the porous silica nanoparticles have a diameter of 50 to 300 nm.

7 . A method of diagnosing viral infection, comprising:
reacting a composition comprising the nanostructure, as an active ingredient, prepared in claim 1 to a virus; and detecting agglomeration of the virus.

8 . A method of preparing a nanostructure for detecting viruses, comprising:
preparing a porous silica nanoparticle by adding a silica precursor to a mixture of surfactants, solvents, and catalysts to carry out a reaction and then washing the reactants; mixing the porous silica nanoparticle with an amphipathic polymer so that the amphipathic polymer is bound to a surface of the porous silica nanoparticle; and mixing the amphipathic polymer-bound silica nanoparticle with a virus antibody so that virus antibody is bound to the amphipathic polymer.

Assignees

• Knu Industry Cooperation Found

Inventors

• Kim Hyun Ouk
• Choi Jae Won
• Shin So Jin
• Ahn Yu Rim
• An Hee Won
• Kim Min Se
• Kim Hak Seon

Classifications

• B82Y15/00

  Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors · CPC title

• B82Y5/00

  Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery · CPC title

• G01N2333/11

  Orthomyxoviridae, e.g. influenza virus · CPC title

• G01N33/56983 Primary

  Viruses · CPC title

• G01N33/552

  Glass or silica · CPC title